154 related articles for article (PubMed ID: 19502161)
21. Hepatic lipid metabolism and non-alcoholic fatty liver disease.
Tessari P; Coracina A; Cosma A; Tiengo A
Nutr Metab Cardiovasc Dis; 2009 May; 19(4):291-302. PubMed ID: 19359149
[TBL] [Abstract][Full Text] [Related]
22. Fat paradox of steatohepatitis.
Tsukamoto H; She H; Hazra S; Cheng J; Wang J
J Gastroenterol Hepatol; 2008 Mar; 23 Suppl 1():S104-7. PubMed ID: 18336651
[TBL] [Abstract][Full Text] [Related]
23. Effect of disease progression on liver apparent diffusion coefficient values in a murine model of NASH at 11.7 Tesla MRI.
Anderson SW; Soto JA; Milch HN; Ozonoff A; O'Brien M; Hamilton JA; Jara HJ
J Magn Reson Imaging; 2011 Apr; 33(4):882-8. PubMed ID: 21448953
[TBL] [Abstract][Full Text] [Related]
24. The farnesoid X receptor (FXR) as a new target in non-alcoholic steatohepatitis.
Cariou B
Diabetes Metab; 2008 Dec; 34(6 Pt 2):685-91. PubMed ID: 19195631
[TBL] [Abstract][Full Text] [Related]
25. The liver and the waistline: Fifty years of growth.
Farrell GC
J Gastroenterol Hepatol; 2009 Oct; 24 Suppl 3():S105-18. PubMed ID: 19799688
[TBL] [Abstract][Full Text] [Related]
26. Adult onset type II citrullinemia as a cause of non-alcoholic steatohepatitis.
Takagi H; Hagiwara S; Hashizume H; Kanda D; Sato K; Sohara N; Kakizaki S; Takahashi H; Mori M; Kaneko H; Ohwada S; Ushikai M; Kobayashi K; Saheki T
J Hepatol; 2006 Jan; 44(1):236-9. PubMed ID: 16278034
[TBL] [Abstract][Full Text] [Related]
27. A protective effect of breastfeeding on the progression of non-alcoholic fatty liver disease.
Nobili V; Bedogni G; Alisi A; Pietrobattista A; Alterio A; Tiribelli C; Agostoni C
Arch Dis Child; 2009 Oct; 94(10):801-5. PubMed ID: 19556219
[TBL] [Abstract][Full Text] [Related]
28. Rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
Imajo K; Yoneda M; Kessoku T; Ogawa Y; Maeda S; Sumida Y; Hyogo H; Eguchi Y; Wada K; Nakajima A
Int J Mol Sci; 2013 Nov; 14(11):21833-57. PubMed ID: 24192824
[TBL] [Abstract][Full Text] [Related]
29. Histopathology of non-alcoholic fatty liver disease.
Brunt EM
Clin Liver Dis; 2009 Nov; 13(4):533-44. PubMed ID: 19818303
[TBL] [Abstract][Full Text] [Related]
30. Non-alcoholic fatty liver disease: is bariatric surgery the answer?
Pillai AA; Rinella ME
Clin Liver Dis; 2009 Nov; 13(4):689-710. PubMed ID: 19818313
[TBL] [Abstract][Full Text] [Related]
31. Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis.
Cusi K
Clin Liver Dis; 2009 Nov; 13(4):545-63. PubMed ID: 19818304
[TBL] [Abstract][Full Text] [Related]
32. Animal models in infection and inflammation - chance and necessity.
Radbruch A; Isaacs J
Eur J Immunol; 2009 Aug; 39(8):1991-3. PubMed ID: 19672889
[TBL] [Abstract][Full Text] [Related]
33. Gene expression profile associated with superimposed non-alcoholic fatty liver disease and hepatic fibrosis in patients with chronic hepatitis C.
Younossi ZM; Afendy A; Stepanova M; Hossain N; Younossi I; Ankrah K; Gramlich T; Baranova A
Liver Int; 2009 Oct; 29(9):1403-12. PubMed ID: 19515216
[TBL] [Abstract][Full Text] [Related]
34. [Influence of bariatric surgery on the non-alcoholic liver steatosis. A histological evaluation].
Ferrer Márquez M; Carvia Pousaillè C; Velasco Albendea J; Rico Morales Mdel M; Casado Martín M; Belda Lozano R; Ferrer Ayza M
Cir Esp; 2009 Aug; 86(2):94-100. PubMed ID: 19560754
[TBL] [Abstract][Full Text] [Related]
35. Not all models of fatty liver are created equal: understanding mechanisms of steatosis development is important.
Larter CZ
J Gastroenterol Hepatol; 2007 Sep; 22(9):1353-4. PubMed ID: 17716338
[No Abstract] [Full Text] [Related]
36. Mouse models of metabolic liver injury.
Ramadori P; Weiskirchen R; Trebicka J; Streetz K
Lab Anim; 2015 Apr; 49(1 Suppl):47-58. PubMed ID: 25835738
[TBL] [Abstract][Full Text] [Related]
37. Serum levels of hyaluronic acid and tissue metalloproteinase inhibitor-1 combined with age predict the presence of nonalcoholic steatohepatitis in a pilot cohort of subjects with nonalcoholic fatty liver disease.
Miele L; Forgione A; La Torre G; Vero V; Cefalo C; Racco S; Vellone VG; Vecchio FM; Gasbarrini G; Rapaccini GL; Neuman MG; Grieco A
Transl Res; 2009 Oct; 154(4):194-201. PubMed ID: 19766963
[TBL] [Abstract][Full Text] [Related]
38. Animal models for the study of hepatic fibrosis.
Starkel P; Leclercq IA
Best Pract Res Clin Gastroenterol; 2011 Apr; 25(2):319-33. PubMed ID: 21497748
[TBL] [Abstract][Full Text] [Related]
39. Pharmacologic therapy of non-alcoholic steatohepatitis.
Ratziu V; Zelber-Sagi S
Clin Liver Dis; 2009 Nov; 13(4):667-88. PubMed ID: 19818312
[TBL] [Abstract][Full Text] [Related]
40. Predictors of steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease.
Pagadala M; Zein CO; McCullough AJ
Clin Liver Dis; 2009 Nov; 13(4):591-606. PubMed ID: 19818307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
